• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“我认为要想实现价值,必须要有相互尊重”:评估患者在一项关于减少低价值医疗服务实施的全国性临床试验中的参与情况。

"I think there has to be a mutual respect for there to be value": Evaluating patient engagement in a national clinical trial on de-implementation of low value care.

作者信息

Etchegary Holly, Linklater Stefanie, Duquette D 'Arcy, Wilkinson Gloria, Francis Vanessa, Gionet Erin, Patey Andrea M, Grimshaw Jeremy M

机构信息

Clinical Epidemiology Program, Faculty of Medicine, Patient Engagement Lead, NL SUPPORT, CIHR-SPOR, Craig L. Dobbin Centre for Genetics, Memorial University, 300 Price Phillip Parkway, Rm 4M210, St. John's, NL, A1B 3V6, Canada.

Department of Medicine, Centre for Implementation Research, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada.

出版信息

Res Involv Engagem. 2023 Aug 26;9(1):70. doi: 10.1186/s40900-023-00483-w.

DOI:10.1186/s40900-023-00483-w
PMID:37633983
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10463407/
Abstract

BACKGROUND

The evaluation of patient engagement in research is understudied and under-reported, making it difficult to know what engagement strategies work best and when. We provide the results of an evaluation of patient engagement in a large Canadian research program focused on the de-implementation of low-value care. We aimed to evaluate the experience and impact of patient engagement in the study.

METHODS

An online cross-sectional survey was administered using Microsoft Forms to (1) researchers and study staff and (2) patient partners. The survey was developed following iterative reviews by the project's patient partnership council and evaluation committee. Survey content areas included opinions on patient engagement to date, including challenges to engagement and suggestions for improvement. Patient partners also evaluated the partnership council. Descriptive statistics including counts and percentages described Likert scale survey items, while open comments were analyzed using descriptive content analysis.

RESULTS

The survey response rate was 46% (17/37). There were positive attitudes about the value of patient engagement in this project. There was also a high degree of willingness to be involved with patient engagement in future projects, whether as a patient partner or as a researcher including patients on the research team. Most patient partners felt their contributions to the project were valued by researchers and study research staff. Open comments revealed that a co-design approach and full inclusion on the research team were integral to demonstrating the value of patient partner input. Areas for improvement included more frequent and ongoing communication among all team members, as well as earlier training about patient engagement, particularly addressing role expectations and role clarity.

CONCLUSIONS

Our data revealed that despite some challenges, team members recognized the value of patient engagement in research and agreed project decisions had been impacted by patient partner input. Ongoing communication was highlighted as an area for improvement, as well as earlier training and ongoing support for all team members, but particularly researchers and study staff. In response to evaluation data, the team has reinstated a quarterly newsletter and plans to use specific patient engagement planning templates across study sites for all project activities. These tools should help make expectations clear for all team members and contribute to a positive patient engagement experience. Findings can inform patient engagement planning and evaluation for other health research projects.

摘要

背景

对患者参与研究的评估研究不足且报道较少,这使得很难知晓哪种参与策略效果最佳以及何时效果最佳。我们提供了一项对加拿大一个大型研究项目中患者参与情况的评估结果,该项目专注于减少低价值医疗服务。我们旨在评估患者参与该研究的体验和影响。

方法

使用微软表单进行了一项在线横断面调查,调查对象为(1)研究人员和研究工作人员以及(2)患者合作伙伴。该调查是在项目的患者合作委员会和评估委员会进行多次迭代审查后制定的。调查内容领域包括对迄今为止患者参与情况的看法,包括参与的挑战和改进建议。患者合作伙伴还对合作委员会进行了评估。描述性统计(包括计数和百分比)用于描述李克特量表调查项目,而开放性评论则使用描述性内容分析进行分析。

结果

调查回复率为46%(17/37)。对于患者参与本项目的价值,大家持积极态度。对于未来项目,无论是作为患者合作伙伴还是作为将患者纳入研究团队的研究人员,参与患者参与活动的意愿也很高。大多数患者合作伙伴认为他们对项目的贡献得到了研究人员和研究工作人员的重视。开放性评论显示,共同设计方法和在研究团队中的充分融入对于证明患者合作伙伴意见的价值至关重要。改进领域包括所有团队成员之间更频繁和持续的沟通,以及更早地开展关于患者参与的培训,特别是明确角色期望和角色清晰度。

结论

我们的数据显示,尽管存在一些挑战,但团队成员认识到患者参与研究的价值,并认同患者合作伙伴的意见对项目决策产生了影响。持续沟通被强调为一个需要改进的领域,同时也需要为所有团队成员,特别是研究人员和研究工作人员提供更早的培训和持续支持。针对评估数据,该团队已恢复每季度发布时事通讯,并计划在所有研究地点为所有项目活动使用特定的患者参与计划模板。这些工具应有助于让所有团队成员明确期望,并有助于营造积极的患者参与体验。研究结果可为其他健康研究项目的患者参与计划和评估提供参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/700b/10463407/3642fc69fd13/40900_2023_483_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/700b/10463407/19c40c73bea5/40900_2023_483_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/700b/10463407/551e8c607e3a/40900_2023_483_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/700b/10463407/3642fc69fd13/40900_2023_483_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/700b/10463407/19c40c73bea5/40900_2023_483_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/700b/10463407/551e8c607e3a/40900_2023_483_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/700b/10463407/3642fc69fd13/40900_2023_483_Fig3_HTML.jpg

相似文献

1
"I think there has to be a mutual respect for there to be value": Evaluating patient engagement in a national clinical trial on de-implementation of low value care.“我认为要想实现价值,必须要有相互尊重”:评估患者在一项关于减少低价值医疗服务实施的全国性临床试验中的参与情况。
Res Involv Engagem. 2023 Aug 26;9(1):70. doi: 10.1186/s40900-023-00483-w.
2
Working together in health research: a mixed-methods patient engagement evaluation.健康研究中的合作:一项混合方法的患者参与度评估
Res Involv Engagem. 2023 Aug 1;9(1):62. doi: 10.1186/s40900-023-00475-w.
3
Activities and impacts of patient engagement in CIHR SPOR funded research: a cross-sectional survey of academic researcher and patient partner experiences.患者参与加拿大卫生研究院战略导向研究项目资助研究的活动及影响:对学术研究人员和患者合作伙伴经历的横断面调查
Res Involv Engagem. 2022 Aug 29;8(1):44. doi: 10.1186/s40900-022-00376-4.
4
Co-building a training programme to facilitate patient, family and community partnership on research grants: A patient-oriented research project.合作共建培训项目,以促进患者、家庭和社区在研究资助方面的伙伴关系:一个以患者为中心的研究项目。
Health Expect. 2023 Aug;26(4):1584-1595. doi: 10.1111/hex.13763. Epub 2023 Apr 20.
5
Lessons learned in measuring patient engagement in a Canada-wide childhood disability network.在加拿大全国性儿童残疾网络中衡量患者参与度所汲取的经验教训。
Res Involv Engagem. 2024 Feb 7;10(1):18. doi: 10.1186/s40900-024-00551-9.
6
Evaluation of a stakeholder advisory board for an adolescent mental health randomized clinical trial.青少年心理健康随机临床试验的利益相关者咨询委员会评估
Res Involv Engagem. 2023 Mar 28;9(1):17. doi: 10.1186/s40900-023-00425-6.
7
Evaluation of an integrated knowledge translation approach used for updating the Cochrane Review of Patient Decision Aids: a pre-post mixed methods study.用于更新《Cochrane患者决策辅助工具综述》的综合知识转化方法的评估:一项前后对比的混合方法研究。
Res Involv Engagem. 2024 Feb 9;10(1):21. doi: 10.1186/s40900-024-00550-w.
8
Evaluating the impact of engaging older adults and service providers as research partners in the co-design of a community mobility-promoting program: a mixed methods developmental evaluation study.评估让老年人和服务提供者作为研究伙伴共同设计社区促进行动能力项目的影响:一项混合方法的发展性评估研究。
Res Involv Engagem. 2023 Dec 8;9(1):116. doi: 10.1186/s40900-023-00523-5.
9
Evolving partnerships: engagement methods in an established health services research team.不断发展的伙伴关系:一个成熟的卫生服务研究团队中的参与方法
Res Involv Engagem. 2021 Oct 9;7(1):71. doi: 10.1186/s40900-021-00314-w.
10
Evaluating the impacts of patient engagement on a national health research network: results of a case study of the Chronic Pain Network.评估患者参与对国家卫生研究网络的影响:慢性疼痛网络案例研究结果
Res Involv Engagem. 2023 Aug 30;9(1):73. doi: 10.1186/s40900-023-00491-w.

引用本文的文献

1
Evaluation Tools for Patient and Public Involvement (PPI) in Health Research: A Scoping Review.健康研究中患者及公众参与(PPI)的评估工具:一项范围综述
Patient. 2025 Sep 5. doi: 10.1007/s40271-025-00765-3.
2
Patient engagement strategies in digital health interventions for cancer survivors: A scoping review.癌症幸存者数字健康干预中的患者参与策略:一项范围综述
PLOS Digit Health. 2025 May 30;4(5):e0000871. doi: 10.1371/journal.pdig.0000871. eCollection 2025 May.
3
Patient and public involvement in neonatal research - experiences and insights from parents and researchers.

本文引用的文献

1
Towards conceptualizing patients as partners in health systems: a systematic review and descriptive synthesis.将患者概念化为卫生系统的合作伙伴:系统评价和描述性综合。
Health Res Policy Syst. 2023 Jan 25;21(1):12. doi: 10.1186/s12961-022-00954-8.
2
Operationalizing a patient engagement plan for health research: Sharing a codesigned planning template from a national clinical trial.将患者参与健康研究计划付诸实践:分享全国临床试验的共同设计规划模板。
Health Expect. 2022 Apr;25(2):697-711. doi: 10.1111/hex.13417. Epub 2021 Dec 24.
3
Developing a Canadian evaluation framework for patient and public engagement in research: study protocol.
患者及公众参与新生儿研究——来自家长和研究人员的经验与见解
Res Involv Engagem. 2025 Jan 6;11(1):1. doi: 10.1186/s40900-024-00670-3.
4
Establishment of a patient and public involvement and engagement group to support clinical trials in Pakistan: Initial lessons learned.成立患者及公众参与和介入小组以支持巴基斯坦的临床试验:初步经验教训
Res Involv Engagem. 2024 Sep 27;10(1):98. doi: 10.1186/s40900-024-00635-6.
5
Recommendations for clinical trial design in acute kidney injury from the 31st acute disease quality initiative consensus conference. A consensus statement.急性肾损伤临床试验设计的建议来自第 31 届急性疾病质量倡议共识会议。一项共识声明。
Intensive Care Med. 2024 Sep;50(9):1426-1437. doi: 10.1007/s00134-024-07560-y. Epub 2024 Aug 8.
6
Patient and public involvement and engagement (PPIE): how valuable and how hard? An evaluation of ALL_EARS@UoS PPIE group, 18 months on.患者及公众参与和介入(PPIE):价值几何,难度几何?对谢菲尔德大学ALL_EARS@UoS PPIE小组开展的为期18个月的评估
Res Involv Engagem. 2024 Apr 11;10(1):38. doi: 10.1186/s40900-024-00567-1.
制定加拿大患者和公众参与研究的评估框架:研究方案
Res Involv Engagem. 2021 Feb 25;7(1):10. doi: 10.1186/s40900-021-00255-4.
4
Researchers, patients, and other stakeholders' perspectives on challenges to and strategies for engagement.研究人员、患者及其他利益相关者对参与面临的挑战及策略的看法。
Res Involv Engagem. 2020 Oct 7;6:60. doi: 10.1186/s40900-020-00227-0. eCollection 2020.
5
Giving patients a voice: a participatory evaluation of patient engagement in Newfoundland and Labrador Health Research.倾听患者心声:对纽芬兰和拉布拉多省卫生研究中患者参与情况的参与式评估
Res Involv Engagem. 2020 Jul 9;6:39. doi: 10.1186/s40900-020-00206-5. eCollection 2020.
6
Guidance on authorship with and acknowledgement of patient partners in patient-oriented research.以患者为导向的研究中患者合作伙伴的作者身份及致谢指南。
Res Involv Engagem. 2020 Jul 2;6:38. doi: 10.1186/s40900-020-00213-6. eCollection 2020.
7
Evaluating the Patient Family Advisor Experience in Patient-Oriented Research.评估患者家属顾问在以患者为导向的研究中的体验。
Healthc Q. 2020 Apr;23(1):28-33. doi: 10.12927/hcq.2020.26142.
8
De-implementing wisely: developing the evidence base to reduce low-value care.明智去执行:为减少低价值医疗建立证据基础。
BMJ Qual Saf. 2020 May;29(5):409-417. doi: 10.1136/bmjqs-2019-010060. Epub 2020 Feb 6.
9
Patient stakeholder engagement in research: A narrative review to describe foundational principles and best practice activities.患者利益相关者参与研究:描述基础原则和最佳实践活动的叙述性综述。
Health Expect. 2019 Jun;22(3):307-316. doi: 10.1111/hex.12873. Epub 2019 Feb 13.
10
Practical Guidance for Involving Stakeholders in Health Research.利益相关者参与健康研究实用指南
J Gen Intern Med. 2019 Mar;34(3):458-463. doi: 10.1007/s11606-018-4738-6. Epub 2018 Dec 18.